中國再生醫學(08158.HK)出售一醫療產品產業基金15%權益
格隆匯1月6日丨中國再生醫學(08158.HK)公告,內容有關公司全資附屬公司CRML(作為B類有限合夥人)參與Haitong International Zhong Hua Finance Acquisition FundI,L.P.(主要投資皮膚護理及醫療產品行業的產業基金),其資本承諾金額為3500萬美元。投資條款主要受經不時修訂的有限合夥協議規管,當中重要條款載於先前公告。
截至本公告日期,CRML已向基金注資總額3500萬美元。根據投資條款,CRML須為基金的日常運營提供額外注資,而截至本公告日期,概無催繳或欠負任何金額。根據本公司於2018年12月31日及截至2018年12月31日止年度的經審核綜合財務報表,投資的公平值(由獨立專業估值師的估值報告支持)為2.98億港元。
於2020年1月6日,CRML、熊千根及普通合夥人訂立一份轉讓契據,據此CRML同意向熊出售投資的15%。
公司主要從事生物醫學和醫療保健產品及醫療技術研發;提供組織工程產品及其相關副產品的生產及銷售;以及銷售及分銷醫療產品及設備。為應對整體經濟狀況變動及業內競爭,公司決定出售出售權益(構成投資的一小部分),以使公司可利用所得現金專注於市場上的其他投資、收購及有機增長機會。本公司計劃將出售事項所得款項用作一般營運資金。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.